基于AAV的1型原蛋白突变的基因编辑,用于治疗骨质变异不完美症
Yeon-Suk Yang1, Tadatoshi Sato1,2,3,4, Sachin Chaugule1
1Department of Medicine, Division of Rheumatology, UMass Chan Medical School, Worcester, MA 01655, USA.
Molecular therapy. Nucleic acids
|January 23, 2024
概括
使用AAV载体传递的CRISPR-Cas9进行基因编辑,纠正了骨质变异不完善 (OI) 小鼠中的原蛋白突变. 这种方法改善了骨质和减少骨折,为OI提供了潜在的治疗策略.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 骨质变异不完美 (OI) 是一种遗传性骨疾病,导致骨脆弱和骨折,通常是由于I型原基因 (COL1A1/COL1A2) 的突变.
- 目前治疗OI的重点是症状管理,而不是解决潜在的遗传原因.
研究的目的:
- 开发和评估使用CRISPR-Cas9的基因组编辑策略,以纠正严重OI的小鼠模型中的Col1a2基因中的特定突变.
- 评估这种基因编辑方法在逆转骨缺陷和改善骨健康方面的有效性.
主要方法:
- 一种复合腺相关病毒 (rAAV) 载体系统被用于将CRISPR-Cas9组件传递给OI小鼠骨架中的骨质细胞.
- 通过将CRISPR-Cas9与含有部分Col1a2cDNA序列的供体AAV载体结合,增强了同质导向修复 (HDR).
- 该策略在体外 (in vitro) 测试了其纠正骨质分化缺陷的能力,并在体内 (in vivo) 通过OI小鼠模型中的全身注射进行了测试.
主要成果:
- 结合AAV-CRISPR-Cas9和供体载体系统,提高了骨质母细胞中HDR介导的基因编辑效率.
- 试验室研究显示,由Col1a2突变引起的骨质分化失调的逆转.
- 在体内,在OI小鼠中,系统性给药导致骨周转率降低,骨细胞网络改善,骨架构,质量和矿物化增强,骨变形和骨折改善.
结论:
- 这项研究表明,通过AAV传递进行HDR介导基因编辑的首次成功应用,以纠正骨质变异不完美的原蛋白突变.
- 这种方法有效地在OI小鼠模型中逆转了骨表型,突出了其作为OI治疗策略的潜力.
- 进一步的研究可能会探索这种基因编辑疗法的长期疗效和安全性.
相关概念视频
Type IV Collagen of Basal Lamina
2.2K
Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
A type IV collagen molecule has six alpha chains which can...
2.2K
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
CRISPR
51.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.0K


